ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Mercachem acquires ADME study specialist Admescope

by Rick Mullin
November 14, 2020 | APPEARED IN VOLUME 98, ISSUE 44

 

MercachemSyncom, a Dutch contract development and manufacturing organization (CDMO), has acquired Admescope, a specialist in pharmaceutical absorption, distribution, metabolism, and excretion studies. Admescope, with dual headquarters in Finland and Sweden, employs about 40 scientists with expertise in drug metabolism, drug interactions, pharmacokinetics, and quantitative bioanalysis. Earlier this year, Mercachem acquired a pharmaceutical chemical development site in Weert, the Netherlands, from the US CDMO Alcami.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment